Sleep-Disordered Breathing and Heart Failure: Focus on Obstructive Sleep Apnea and Treatment With Continuous Positive Airway Pressure

Journal of Cardiac Failure

Volumn 16, Issue 2, 2010, Pages 164-174

  Chowdhury, Mahdi ^a   Adams, Suzanne ^b   Whellan, David J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

CPAP; heart failure; sleep apnea; sleep disordered breathing

Indexed keywords

BLOOD PRESSURE; BREATHING; CENTRAL SLEEP APNEA SYNDROME; DIASTOLIC HEART FAILURE; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MORTALITY; MUSCLE REFLEX; OROPHARYNX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SOMNOLENCE; SYMPATHETIC TONE; UPPER RESPIRATORY TRACT;

ANIMALS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART FAILURE; HUMANS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 75349102354     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.08.006     Document Type: Review

References (92)

1. American Heart Association. Heart disease and stroke statistics - 2007 update (2007), American Heart Association, Dallas, TX
2. Hiestand D.M., Britz P., Goldman M., and Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll. Chest 130 (2006) 780-786
3. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52 (2008) 686-717
4. Bradley T.D., and Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373 (2009) 82-93
5. Floras J.S. Should sleep apnoea be a specific target of therapy in heart failure?. Heart 95 (2009) 1041-1046
6. Iber C., Ancoli-Israel S., Chesson A.L., and Quan S. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specification (2007), American Academy of Sleep Medicine, Westchester, IL
7. EEG arousals. scoring rules and examples: a preliminary report from the sleep disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15 (1992) 173-184
8. Kushida C.A., Chang A., Gadkary C., Guilleminault C., Carrillo O., and Dement W.C. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med 2 (2001) 389-396
9. Yoon I.Y., Kripke D.F., Youngstedt S.D., and Elliott J.A. Actigraphy suggests age-related differences in napping and nocturnal sleep. J Sleep Res 12 (2003) 87-93
10. Javaheri S., Parker T.J., Wexler L., Michaels S.E., Stanberry E., Nishyama H., et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122 (1995) 487-492
11. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
12. Sleep-related breathing disorders in adults. recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
13. Bradley T.D., and Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107 (2003) 1671-1678
14. Somers V.K., Mark A.L., Zavala D.C., and Abboud F.M. Contrasting effects of hypoxia and hypercapnea on ventilation and sympathetic activity in humans. J Appl Physiol 67 (1989) 2101-2106
15. Solin P., Kaye D.M., Little P.J., Bergin P., Richardson M., and Naughton M.T. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123 (2003) 1119-1126
16. Noda A., Yasuma F., Okada T., and Yokota M. Circadian rhythm of autonomic activity in patients with obstructive sleep apnea syndrome. Clin Cardiol 21 (1998) 271-276
17. Gami A.S., Hodge D.O., Herges R.M., Olson E.J., Nykodym J., Kara T., et al. Obstructive sleep apnea, obesity, and the risk on incident atrial fibrillation. J Am Coll Cardiol 49 (2007) 565-571
18. Ryan C.M., Usui K., Floras J.S., and Bradley T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60 (2005) 781-785
19. Malone S., Liu P.P., Holloway R., Rutherford R., Xie A., and Bradley T.D. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338 (1991) 1480-1484
20. Sin D.D., Fitzgerald F., Parker J.D., Newton G.E., Logan A.G., Floras J.S., et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123 (2003) 1536-1543
21. Laaban J.P., Pascal-Sebaoun S., Bloch E., Prvoen-Frija E., Oppert J.M., and Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 122 (2002) 1133-1138
22. Alchanatis M., Paradellis G., Pini H., Tourkohoriti G., and Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 67 (2000) 367-371
23. Shivalkar B., Van De Heyning C., Kerremans M., Rinkevich D., Verbraeken J., De Backer W., et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47 (2006) 1433-1439
24. Bradley T.D., Hall M.J., Ando S., and Floras J.S. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 119 (2001) 1827-1835
25. Naughton M., Benard D., Tam A., Rutherford R., and Bradley T.D. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148 (1993) 330-338
26. Solin P., Bergin P., Richardson M., Kaye D.M., Walters E.H., and Naughton M.T. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99 (1999) 1574-1579
27. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341 (1999) 949-954
28. Javaheri S., and Corbett W.S. Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 128 (1998) 204-207
29. Bradley T.D., and Phillipson E.A. Central sleep apnea. Clin Chest Med 13 (1992) 493-505
30. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respr Crit Care Med 163 (2001) 19-25
31. Javaheri S., Parker T.J., Liming J.D., Corbett W.S., Nishiyama H., Wexler L., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
32. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106 (2006) 21-28
33. Vazir A., Hastings P.C., Dayer M., McIntyre H.F., Henein M.Y., Poole-Wilson P.A., et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Failure 9 (2007) 243-250
34. Wang H., Parker J.D., Newton G.E., Floras J.S., Mak S., Chiu K.L., et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49 (2007) 1625-1631
35. Lofaso F., Verschueren P., Randle J.L., Harf A., and Goldenberg F. Prevalence of sleep-disordered breathing in patients on a heart transplant list. Chest 106 (1994) 1689-1694
36. Rao A., Georgiadou P., Francis D.P., Johnson A., Kremastinos D.T., Simonds A.K., et al. Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res 15 (2006) 81-88
37. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
38. Kohnlein T., and Welte T. Does beta-blocker treatment influence central sleep apnoea?. Respir Med 101 (2007) 850-853
39. Yumino D., Wang H., Floras J.S., Newton G.E., Mak S., Ruttanaumpawan P., et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15 (2009) 279-285
40. Sin D.D., Fitzgerald F., Parker J.D., Newton G., Floras J.S., and Bradley T.D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160 (1999) 1101-1106
41. Ferrier K., Campbell A., Yee B., Richards M., O'Meeghan T., Weatherall M., et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128 (2005) 2116-2122
42. Mihaere K., Gander P., and Reid P. Prevalence of obstructive sleep apnea amongst adult Maori and non-Maori in a New Zealand community sample. Sleep 26 (2003) A237
43. Oldenburg O., Lamp B., Faber L., Teschler H., Horstkotte D., and Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure 9 (2007) 251-257
44. Tkacova R., Niroumand M., Lorenzi-Filho G., and Bradley T.D. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103 (2001) 238-243
45. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep disordered breathing in among middle aged adults. N Engl J Med 328 (1993) 1230-1235
46. Chan J., Sanderson J., Chan W., Lai C., Choy D., Ho A., et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111 (1997) 1488-1493
47. Lew R.A., and Baertschi A.J. Mechanisms of hypoxia-induced atrial natriuretic factor release from rat hearts. Am J Physiol 257 (1989) H147-H156
48. Raine A.E., Erne P., Burgisser E., Muller F.B., Bolli P., Burkart F., et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315 (1986) 533-537
49. Baruzzi A., Riva R., Cirignotta F., Zucconi M., Cappelli M., and Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14 (1991) 83-86
50. Krieger J., Follenius M., Sforza E., Brandenberger G., and Peter J.D. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci Lond 80 (1991) 443-449
51. Anand I.S., Fisher L.D., Chiang Y.T., Latini R., Masson S., Maggioni A.P., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003) 1278-1283
52. Ferrier K.A., Neill A.M., O'Meeghan T., Richards M., and Campbell A.K. Continuous positive airway pressure in heart failure patients with obstructive sleep apnoea. Intern Med J 38 (2008) 829-836
53. Lindenfeld J. Prevalence of anemia and the effects on mortality in patients with heart failure. Am Heart J 149 (2005) 391-401
54. Silverberg D.S., Wexler D., Blum M., Keren G., Sheps D., Leibovitch E., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
55. Zilberman M., Silverberg D.S., Bits I., Steinbruch S., Wexler D., Sheps D., et al. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. Am Heart J 154 (2007) 870-876
56. Buda A.J., Li Y., Brant D., Krause L.C., and Julius S. Changes in left ventricular diastolic filling during the development of left ventricular hypertrophy: observations using Doppler echocardiography in a unique canine model. Am Heart J 121 (1991) 1759-1767
57. Otto M.E., Belohlavek M., Romero-Corral A., Gami A.S., Gilman G., Svatikova A., et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99 (2007) 1298-1302
58. Usui K., Parker J.D., Newton G.E., Floras J.S., Ryan C.M., and Bradley T.D. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 173 (2006) 1170-1175
59. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
60. Gottdiener J.S., McClelland R.L., Marshall R., Shemanski L., Furberg C.D., Kitzman D.W., et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137 (2002) 631-639
61. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
62. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
63. Solomon S.D., Anavekar N., Skali H., McMurray J.J., Swedberg K., Yusuf S., et al. Influence of ejection fraction on cardiovascular outcomes in broad spectrum of heart failure patients. Circulation 24 (2005) 3738-3744
64. Kaneko Y., Floras J.S., Usui K., Plante J., Tkacova R., Kubo T., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003) 1233-1241
65. Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., and Naughton M.T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 (2004) 361-366
66. Smith L.A., Vennelle M., Gardner R.S., McDonagh T.A., Denvir M.A., Douglas N.J., et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28 (2007) 1221-1227
67. Masa J.F., Jimenez A., Duran J., Capote F., Monasterio C., Mayos M., et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 170 (2004) 1218-1224
68. Massie C.A., McArdle N., Hart R.W., Schmidt-Nowara W.W., Lankford A., Hudgel D.W., et al. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med 167 (2003) 20-23
69. Egea C.J., Aizpuru F., Pinto J.A., Ayuela J.M., Ballester E., Zamarron C., et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med 9 (2008) 660-666
70. Tkacova R., Rankin F., Fitzgerald F.S., Floras J.S., and Bradley T.D. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98 (1998) 2269-2275
71. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., and Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26 (1995) 1257-1263
72. Mann D.L., Kent R.L., Parsons B., and Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 (1992) 790-804
73. Schwartz P.J., Billman G.E., and Stone H.L. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia in dogs with healed myocardial infarction. Circulation 69 (1984) 790-800
74. Usui K., Bradley T.D., Spaak J., Ryan C.M., Kubo T., Kaneko Y., et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45 (2005) 2008-2011
75. Spaak J., Egri Z.J., Kubo T., Yu E., Ando S., Kaneko Y., et al. Increased daytime sympathetic nerve activity in heart failure patients with sleep apnea. Hypertension 46 (2005) 1327-1332
76. Sarnoff S.J., Braunwald E., Welch Jr. G.H., Case R.B., Stainsby W.N., and Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to tension-time index. Am J Physiol 192 (1958) 148-156
77. George C.F. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 56 (2001) 508-512
78. Pepperell J.C., Maskell N.A., Jones D.R., Langford-Wiley B.A., Crosthwaite N., Stradling J.R., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168 (2003) 1109-1114
79. Chervin R.D., and Aldrich M.S. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 52 (1999) 125-131
80. Gottlieb D.J., Whitney C.W., Bonekat W.H., Iber C., James G.D., Lebowitz M., et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 159 (1999) 502-507
81. Artz M., Young T., Finn L., Skatrud J.B., Ryan C.M., Newton G.E., et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166 (2006) 1716-1722
82. Montserrat J.M., Ferrer M., Hernández L., Farre R., Vilagut G., Navajas D., et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 164 (2001) 608-613
83. Becker H.F., Jerrentrup A., Ploch T., Grote L., Penzel T., Sullivan C.E., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnoea. Circulation 107 (2003) 68-73
84. Hack M., Davies R.J., Mullins R., Choi S.J., Ramdassingh-Dow S., Jenkinson C., et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnea. Thorax 55 (2000) 224-231
85. Jenkinson C., Davies R.J., Mullins R., and Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353 (1999) 2100-2105
86. Henke K.G., Grady J.J., and Kuna S.T. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 163 (2001) 911-917
87. Hastings P.C., Vazir A., O'Driscoll D.M., Morrell M.J., and Simonds A.K. Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 27 (2006) 748-755
88. Kasai T., Narui K., Dohi T., Yanagisawa N., Ishiwata S., Ohno M., et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133 (2008) 690-696
89. Bradley T.D., Logan A.G., Kimoff J., Series F., Morrison D., Ferguson K., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
90. Khayat R.N., Abraham W.T., Patt B., Roy M., Hua K., and Jarjoura D. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study. Chest 134 (2008) 1162-1168
91. Eskafi M., Cline C., Nilner M., and Israelsson B. Treatment of sleep apnea in congestive heart failure with a dental device. Sleep Breath 10 (2006) 90-97
92. Stanchina M.L., Ellison K., Malhotra A., Anderson M., Kirk M., Benser M.E., et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 132 (2007) 433-439